Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma

oleh: Michelle A. McNally, BSN, Ramya Vangipuram, MD, Matthew T. Campbell, MD, Priyadharsini Nagarajan, MD, PhD, Anisha B. Patel, MD, Jonathan L. Curry, MD, Meghan Heberton, MD

Format: Article
Diterbitkan: Elsevier 2021-04-01

Deskripsi

Subjek

anti-programmed-death-1; dermatologic toxicities; immune checkpoints inhibitors; immune-related adverse event; paraneoplastic pemphigus; pembrolizumab